CSF-PR

CSF-PR aggregates quantitative cerebrospinal fluid (CSF) mass spectrometry–based proteomics data from the peer-reviewed literature to support comparative analysis of protein abundances across neurological disorders, including multiple sclerosis, Alzheimer's disease, and Parkinson's disease.

Key Features:

• Data aggregation: Mines peer-reviewed literature to compile mass spectrometry–based proteomics studies and extract quantitative protein data from CSF samples.
• Disease coverage: Focuses on protein abundance data associated with multiple sclerosis, Alzheimer's disease, and Parkinson's disease.
• Comparative analysis: Enables comparison of protein abundances across disease groups and subcategories to reveal increases or decreases in specific proteins.
• Visualization tools: Provides visual representations of abundance changes across diseases to aid identification of potential biomarkers and interpretation of disease mechanisms.
• Data export: Supplies compiled quantitative proteomics data for integration into downstream analyses or publications.

Scientific Applications:

• Biomarker discovery: Supports identification of CSF proteins with differential abundance across neurological disorders for candidate biomarkers.
• Comparative proteomics: Facilitates cross-disease comparisons among multiple sclerosis, Alzheimer's disease, and Parkinson's disease to identify shared and distinct proteomic signatures.
• Literature synthesis and meta-analysis: Provides a curated compilation of quantitative CSF proteomics results to enable synthesis of published findings without individual study re-review.

Methodology:

Systematically mines peer-reviewed literature to extract quantitative mass spectrometry–based proteomics data from cerebrospinal fluid (CSF) studies.